A detailed history of Concourse Financial Group Securities, Inc. transactions in Novo Nordisk A S stock. As of the latest transaction made, Concourse Financial Group Securities, Inc. holds 47,082 shares of NVO stock, worth $5.85 Million. This represents 0.43% of its overall portfolio holdings.

Number of Shares
47,082
Previous 47,275 0.41%
Holding current value
$5.85 Million
Previous $6.07 Million 10.71%
% of portfolio
0.43%
Previous 0.4%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 23, 2024

SELL
$122.71 - $146.91 $23,683 - $28,353
-193 Reduced 0.41%
47,082 $6.72 Million
Q1 2024

Apr 30, 2024

BUY
$102.11 - $135.92 $1.02 Million - $1.36 Million
10,023 Added 26.91%
47,275 $6.07 Million
Q4 2023

Feb 07, 2024

BUY
$87.78 - $105.45 $252,630 - $303,485
2,878 Added 8.37%
37,252 $3.85 Million
Q3 2023

Oct 25, 2023

BUY
$90.94 - $199.54 $1.58 Million - $3.46 Million
17,334 Added 101.73%
34,374 $3.13 Million
Q2 2023

Aug 10, 2023

BUY
$155.98 - $172.65 $1.39 Million - $1.53 Million
8,881 Added 108.85%
17,040 $2.76 Million
Q1 2023

May 15, 2023

SELL
$132.34 - $159.14 $26,600 - $31,987
-201 Reduced 2.4%
8,159 $1.3 Million
Q4 2022

Jan 30, 2023

BUY
$102.55 - $135.33 $6,358 - $8,390
62 Added 0.75%
8,360 $0
Q3 2022

Nov 15, 2022

SELL
$95.28 - $116.93 $12,100 - $14,850
-127 Reduced 1.51%
8,298 $827,000
Q2 2022

Aug 09, 2022

BUY
$103.24 - $121.81 $783,591 - $924,537
7,590 Added 908.98%
8,425 $939,000
Q1 2022

May 09, 2022

SELL
$93.1 - $112.54 $69,359 - $83,842
-745 Reduced 47.15%
835 $94,000
Q4 2021

Feb 07, 2022

BUY
$95.88 - $117.08 $15,532 - $18,966
162 Added 11.42%
1,580 $177,000
Q3 2021

Nov 09, 2021

BUY
$84.42 - $106.62 $79,270 - $100,116
939 Added 196.03%
1,418 $136,000
Q2 2021

Aug 13, 2021

SELL
$67.66 - $84.76 $879 - $1,101
-13 Reduced 2.64%
479 $40,000
Q1 2021

May 13, 2021

BUY
$67.06 - $75.82 $1,408 - $1,592
21 Added 4.46%
492 $34,000
Q4 2020

Feb 02, 2021

SELL
$63.89 - $73.8 $4,280 - $4,944
-67 Reduced 12.45%
471 $33,000
Q3 2020

Nov 13, 2020

SELL
$63.69 - $70.22 $18,215 - $20,082
-286 Reduced 34.71%
538 $37,000
Q2 2020

Aug 13, 2020

SELL
$58.54 - $67.94 $1,463 - $1,698
-25 Reduced 2.94%
824 $54,000
Q1 2020

May 13, 2020

SELL
$49.46 - $64.78 $52,922 - $69,314
-1,070 Reduced 55.76%
849 $52,000
Q4 2019

Feb 14, 2020

BUY
$49.86 - $58.26 $21,639 - $25,284
434 Added 29.23%
1,919 $111,000
Q3 2019

Nov 13, 2019

SELL
$47.54 - $53.43 $285 - $320
-6 Reduced 0.4%
1,485 $77,000
Q2 2019

Aug 13, 2019

BUY
$46.79 - $52.47 $10,668 - $11,963
228 Added 18.05%
1,491 $76,000
Q1 2019

May 15, 2019

BUY
$46.36 - $52.63 $14,835 - $16,841
320 Added 33.93%
1,263 $66,000
Q4 2018

Feb 14, 2019

BUY
$41.54 - $47.25 $5,358 - $6,095
129 Added 15.85%
943 $43,000
Q3 2018

Nov 13, 2018

BUY
$46.76 - $51.24 $38,062 - $41,709
814 New
814 $38,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $281B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Concourse Financial Group Securities, Inc. Portfolio

Follow Concourse Financial Group Securities, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Concourse Financial Group Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Concourse Financial Group Securities, Inc. with notifications on news.